{"id":16850,"date":"2026-07-24T12:17:11","date_gmt":"2026-07-24T10:17:11","guid":{"rendered":"https:\/\/q-finity.de\/eu-gmp-annex-22\/"},"modified":"2026-09-04T18:13:50","modified_gmt":"2026-09-04T16:13:50","slug":"eu-gmp-annex-22","status":"publish","type":"page","link":"https:\/\/q-finity.de\/en\/eu-gmp-annex-22\/","title":{"rendered":"EU GMP Annex 22"},"content":{"rendered":"\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":3,"featured_media":16858,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"inline_featured_image":false,"footnotes":""},"class_list":["post-16850","page","type-page","status-publish","has-post-thumbnail","hentry"],"yoast_head":"\nEU GMP Annex 22 Draft: The AI Annex | QFINITY<\/title>\n<meta name=\"description\" content=\"EU GMP Annex 22 governs AI models in pharmaceutical manufacturing: what the draft requires, where the text stands, and how to build your readiness today.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/q-finity.de\/en\/eu-gmp-annex-22\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EU GMP Annex 22 Draft: The AI Annex | QFINITY\" \/>\n<meta property=\"og:description\" content=\"EU GMP Annex 22 governs AI models in pharmaceutical manufacturing: what the draft requires, where the text stands, and how to build your readiness today.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/q-finity.de\/en\/eu-gmp-annex-22\/\" \/>\n<meta property=\"og:site_name\" content=\"QFINITY\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-04T16:13:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mlsqau6zetur.i.optimole.com\/cb:mN7M.c4bb\/w:auto\/h:auto\/q:mauto\/f:best\/https:\/\/q-finity.de\/wp-content\/uploads\/2026\/07\/annex-22-hero-e2.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"EU GMP Annex 22\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/q-finity.de\\\/en\\\/eu-gmp-annex-22\\\/\",\"url\":\"https:\\\/\\\/q-finity.de\\\/en\\\/eu-gmp-annex-22\\\/\",\"name\":\"EU GMP Annex 22 Draft: The AI Annex | QFINITY\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/q-finity.de\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/q-finity.de\\\/en\\\/eu-gmp-annex-22\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/q-finity.de\\\/en\\\/eu-gmp-annex-22\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\/\\/q-finity.de\\/wp-content\\/uploads\\/2026\\/07\\/annex-22-hero-e2.png\",\"datePublished\":\"2026-07-24T10:17:11+00:00\",\"dateModified\":\"2026-09-04T16:13:50+00:00\",\"description\":\"EU GMP Annex 22 governs AI models in pharmaceutical manufacturing: what the draft requires, where the text stands, and how to build your readiness today.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/q-finity.de\\\/en\\\/eu-gmp-annex-22\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/q-finity.de\\\/en\\\/eu-gmp-annex-22\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/q-finity.de\\\/en\\\/eu-gmp-annex-22\\\/#primaryimage\",\"url\":\"https:\\/\\/q-finity.de\\/wp-content\\/uploads\\/2026\\/07\\/annex-22-hero-e2.png\",\"contentUrl\":\"https:\\/\\/q-finity.de\\/wp-content\\/uploads\\/2026\\/07\\/annex-22-hero-e2.png\",\"width\":1920,\"height\":1071,\"caption\":\"EU GMP Annex 22 - the AI annex to the EU GMP guideline crystallizing out of the consultation\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/q-finity.de\\\/en\\\/eu-gmp-annex-22\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/q-finity.de\\\/en\\\/home\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EU GMP Annex 22\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/q-finity.de\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/q-finity.de\\\/en\\\/\",\"name\":\"QFINITY\",\"description\":\"Qualit\u00e4tsmanagement & - sicherung\",\"publisher\":{\"@id\":\"https:\\\/\\\/q-finity.de\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/q-finity.de\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/q-finity.de\\\/en\\\/#organization\",\"name\":\"QFINITY\u221e\",\"url\":\"https:\\\/\\\/q-finity.de\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/q-finity.de\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\/\\/mlsqau6zetur.i.optimole.com\\/cb:frAi.c2d9\\/w:512\\/h:512\\/q:mauto\\/f:best\\/https:\\/\\/q-finity.de\\/wp-content\\/uploads\\/2021\\/03\\/cropped-cropped-signet_PAN_orange.png\",\"contentUrl\":\"https:\\/\\/mlsqau6zetur.i.optimole.com\\/cb:frAi.c2d9\\/w:512\\/h:512\\/q:mauto\\/f:best\\/https:\\/\\/q-finity.de\\/wp-content\\/uploads\\/2021\\/03\\/cropped-cropped-signet_PAN_orange.png\",\"width\":512,\"height\":512,\"caption\":\"QFINITY\u221e\"},\"image\":{\"@id\":\"https:\\\/\\\/q-finity.de\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/q-finity-quality-management\\\/\",\"https:\\\/\\\/www.instagram.com\\\/qfinity_official\\\/\",\"https:\\\/\\\/www.wikidata.org\\\/wiki\\\/Q141257555\"],\"founder\":{\"@id\":\"https:\\\/\\\/q-finity.de\\\/en\\\/#founder\"}},{\"@type\":\"FAQPage\",\"@id\":\"https:\\\/\\\/q-finity.de\\\/en\\\/eu-gmp-annex-22\\\/#faq\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"When does Annex 22 take effect?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No date is set. The consultation closed in October 2025 and the EMA's two-day expert workshop took place on 30 June and 1 July 2026; a workshop report has been announced, with a revised draft expected next, followed by finalization and transition periods. Until then, the computerized system is validated under Annex 11; quality risk management under ICH Q9(R1) guides the depth of evidence.\"}},{\"@type\":\"Question\",\"name\":\"Does Annex 22 apply to LLMs and generative AI?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Formally, generative AI and LLMs fall outside its scope. The draft nevertheless makes a clear statement about them: they should not be used in critical GMP applications, and the evidence sections apply only to static models with deterministic output. Outside critical applications their use remains possible, always with human review of the outputs, and responsibility stays with the regulated company. This very boundary is the central point of contention in the consultation, and the final text may read differently here.\"}},{\"@type\":\"Question\",\"name\":\"Does Annex 22 replace Annex 11?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No. Annex 22 is designed as supplementary guidance to Annex 11: the computerized system remains validated under Annex 11; Annex 22 additionally governs the evidence for the embedded model, from intended use to operation.\"}},{\"@type\":\"Question\",\"name\":\"How do the model, the AI system and the AI subsystem relate?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Annex 22 focuses on the model: training, testing and the evidence of its fitness for purpose. We take a wider view: an AI system or AI subsystem brings together one or more models and additional functions, such as controls (often called \\\"guardrails\\\"), into a single system component. Performance can then be measured at several levels, so the fitness for purpose of each subcomponent, and of their interplay, can be assessed.\"}},{\"@type\":\"Question\",\"name\":\"What does Annex 22 require of personnel?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Section 2.1 of the draft calls for close cooperation between everyone involved, from algorithm selection through training, validation and testing to operation. It names process SMEs, QA, data scientists, IT and external consultants, each with adequate qualifications, defined responsibilities and an appropriate level of access. Where generative models run outside critical applications, qualified personnel remain responsible for ensuring the outputs are suitable for the intended use. This cooperation is also Knowledge Management in the sense of ICH Q10, where it stands alongside quality risk management as one of the two enablers of the quality system: knowledge about models, data and their limits stays with the organization, not with individuals.\"}},{\"@type\":\"Question\",\"name\":\"What can regulated companies do today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Everything that matters: inventory the AI applications, document intended use and criticality, define test metrics, secure independent test data, establish monitoring and human oversight. Every one of these building blocks can be implemented today under Annex 11, with ICH Q9(R1) informing how deep the evidence needs to go. The draft makes much of this explicit for AI models and in places demands more.\"}}],\"isPartOf\":{\"@id\":\"https:\\\/\\\/q-finity.de\\\/en\\\/eu-gmp-annex-22\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/q-finity.de\\\/en\\\/#founder\",\"name\":\"Oliver Herrmann\",\"jobTitle\":\"Founder & CEO\",\"url\":\"https:\\\/\\\/q-finity.de\\\/en\\\/\",\"worksFor\":{\"@id\":\"https:\\\/\\\/q-finity.de\\\/en\\\/#organization\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/in\\\/olherrmann\\\/\",\"https:\\\/\\\/virtual.ispe.org\\\/b\\\/sp\\\/oliver-herrmann-4399\",\"https:\\\/\\\/www.wikidata.org\\\/wiki\\\/Q141257562\"],\"knowsAbout\":[\"GxP-Compliance\",\"Computer System Validation\",\"Computer Software Assurance\",\"Data Integrity\",\"ALCOA++\",\"AI Governance\",\"GAMP 5\"],\"image\":\"https:\\/\\/q-finity.de\\/wp-content\\/uploads\\/2026\\/06\\/oliver-herrmann-qfinity-ceo-scaled.jpg\",\"description\":\"Founder and CEO of QFINITY, GAMP Europe Chair, qualified GAMP 5 and GAMP Data Integrity trainer, GQMA auditor and international speaker. Co-author of several ISPE GAMP guides, including the GAMP 5 Guide (2nd Edition).\",\"memberOf\":{\"@type\":\"Organization\",\"name\":\"International Society for Pharmaceutical Engineering (ISPE)\",\"url\":\"https:\\\/\\\/ispe.org\"},\"hasCredential\":[{\"@type\":\"EducationalOccupationalCredential\",\"credentialCategory\":\"degree\",\"name\":\"Graduate Computer Scientist (Dipl.-Inf.)\"},{\"@type\":\"EducationalOccupationalCredential\",\"credentialCategory\":\"certification\",\"name\":\"Microsoft Certified Systems Engineer (MCSE)\"},{\"@type\":\"EducationalOccupationalCredential\",\"credentialCategory\":\"certification\",\"name\":\"SAFe (Scaled Agile Framework)\"}]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"EU GMP Annex 22 Draft: The AI Annex | QFINITY","description":"EU GMP Annex 22 governs AI models in pharmaceutical manufacturing: what the draft requires, where the text stands, and how to build your readiness today.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/q-finity.de\/en\/eu-gmp-annex-22\/","og_locale":"en_US","og_type":"article","og_title":"EU GMP Annex 22 Draft: The AI Annex | QFINITY","og_description":"EU GMP Annex 22 governs AI models in pharmaceutical manufacturing: what the draft requires, where the text stands, and how to build your readiness today.","og_url":"https:\/\/q-finity.de\/en\/eu-gmp-annex-22\/","og_site_name":"QFINITY","article_modified_time":"2026-09-04T16:13:50+00:00","og_image":[{"url":"https:\/\/mlsqau6zetur.i.optimole.com\/cb:mN7M.c4bb\/w:auto\/h:auto\/q:mauto\/f:best\/https:\/\/q-finity.de\/wp-content\/uploads\/2026\/07\/annex-22-hero-e2.png","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_title":"EU GMP Annex 22","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/q-finity.de\/en\/eu-gmp-annex-22\/","url":"https:\/\/q-finity.de\/en\/eu-gmp-annex-22\/","name":"EU GMP Annex 22 Draft: The AI Annex | QFINITY","isPartOf":{"@id":"https:\/\/q-finity.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/q-finity.de\/en\/eu-gmp-annex-22\/#primaryimage"},"image":{"@id":"https:\/\/q-finity.de\/en\/eu-gmp-annex-22\/#primaryimage"},"thumbnailUrl":"https:\/\/mlsqau6zetur.i.optimole.com\/cb:mN7M.c4bb\/w:auto\/h:auto\/q:mauto\/f:best\/https:\/\/q-finity.de\/wp-content\/uploads\/2026\/07\/annex-22-hero-e2.png","datePublished":"2026-07-24T10:17:11+00:00","dateModified":"2026-09-04T16:13:50+00:00","description":"EU GMP Annex 22 governs AI models in pharmaceutical manufacturing: what the draft requires, where the text stands, and how to build your readiness today.","breadcrumb":{"@id":"https:\/\/q-finity.de\/en\/eu-gmp-annex-22\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/q-finity.de\/en\/eu-gmp-annex-22\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/q-finity.de\/en\/eu-gmp-annex-22\/#primaryimage","url":"https:\/\/mlsqau6zetur.i.optimole.com\/cb:mN7M.c4bb\/w:auto\/h:auto\/q:mauto\/f:best\/https:\/\/q-finity.de\/wp-content\/uploads\/2026\/07\/annex-22-hero-e2.png","contentUrl":"https:\/\/mlsqau6zetur.i.optimole.com\/cb:mN7M.c4bb\/w:auto\/h:auto\/q:mauto\/f:best\/https:\/\/q-finity.de\/wp-content\/uploads\/2026\/07\/annex-22-hero-e2.png","width":1920,"height":1071,"caption":"EU GMP Annex 22 - the AI annex to the EU GMP guideline crystallizing out of the consultation"},{"@type":"BreadcrumbList","@id":"https:\/\/q-finity.de\/en\/eu-gmp-annex-22\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/q-finity.de\/en\/home\/"},{"@type":"ListItem","position":2,"name":"EU GMP Annex 22"}]},{"@type":"WebSite","@id":"https:\/\/q-finity.de\/en\/#website","url":"https:\/\/q-finity.de\/en\/","name":"QFINITY","description":"Qualit\u00e4tsmanagement & - sicherung","publisher":{"@id":"https:\/\/q-finity.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/q-finity.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/q-finity.de\/en\/#organization","name":"QFINITY\u221e","url":"https:\/\/q-finity.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/q-finity.de\/en\/#\/schema\/logo\/image\/","url":"https:\/\/mlsqau6zetur.i.optimole.com\/cb:frAi.c2d9\/w:512\/h:512\/q:mauto\/f:best\/https:\/\/q-finity.de\/wp-content\/uploads\/2021\/03\/cropped-cropped-signet_PAN_orange.png","contentUrl":"https:\/\/mlsqau6zetur.i.optimole.com\/cb:frAi.c2d9\/w:512\/h:512\/q:mauto\/f:best\/https:\/\/q-finity.de\/wp-content\/uploads\/2021\/03\/cropped-cropped-signet_PAN_orange.png","width":512,"height":512,"caption":"QFINITY\u221e"},"image":{"@id":"https:\/\/q-finity.de\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/q-finity-quality-management\/","https:\/\/www.instagram.com\/qfinity_official\/","https:\/\/www.wikidata.org\/wiki\/Q141257555"],"founder":{"@id":"https:\/\/q-finity.de\/en\/#founder"}},{"@type":"FAQPage","@id":"https:\/\/q-finity.de\/en\/eu-gmp-annex-22\/#faq","mainEntity":[{"@type":"Question","name":"When does Annex 22 take effect?","acceptedAnswer":{"@type":"Answer","text":"No date is set. The consultation closed in October 2025 and the EMA's two-day expert workshop took place on 30 June and 1 July 2026; a workshop report has been announced, with a revised draft expected next, followed by finalization and transition periods. Until then, the computerized system is validated under Annex 11; quality risk management under ICH Q9(R1) guides the depth of evidence."}},{"@type":"Question","name":"Does Annex 22 apply to LLMs and generative AI?","acceptedAnswer":{"@type":"Answer","text":"Formally, generative AI and LLMs fall outside its scope. The draft nevertheless makes a clear statement about them: they should not be used in critical GMP applications, and the evidence sections apply only to static models with deterministic output. Outside critical applications their use remains possible, always with human review of the outputs, and responsibility stays with the regulated company. This very boundary is the central point of contention in the consultation, and the final text may read differently here."}},{"@type":"Question","name":"Does Annex 22 replace Annex 11?","acceptedAnswer":{"@type":"Answer","text":"No. Annex 22 is designed as supplementary guidance to Annex 11: the computerized system remains validated under Annex 11; Annex 22 additionally governs the evidence for the embedded model, from intended use to operation."}},{"@type":"Question","name":"How do the model, the AI system and the AI subsystem relate?","acceptedAnswer":{"@type":"Answer","text":"Annex 22 focuses on the model: training, testing and the evidence of its fitness for purpose. We take a wider view: an AI system or AI subsystem brings together one or more models and additional functions, such as controls (often called \"guardrails\"), into a single system component. Performance can then be measured at several levels, so the fitness for purpose of each subcomponent, and of their interplay, can be assessed."}},{"@type":"Question","name":"What does Annex 22 require of personnel?","acceptedAnswer":{"@type":"Answer","text":"Section 2.1 of the draft calls for close cooperation between everyone involved, from algorithm selection through training, validation and testing to operation. It names process SMEs, QA, data scientists, IT and external consultants, each with adequate qualifications, defined responsibilities and an appropriate level of access. Where generative models run outside critical applications, qualified personnel remain responsible for ensuring the outputs are suitable for the intended use. This cooperation is also Knowledge Management in the sense of ICH Q10, where it stands alongside quality risk management as one of the two enablers of the quality system: knowledge about models, data and their limits stays with the organization, not with individuals."}},{"@type":"Question","name":"What can regulated companies do today?","acceptedAnswer":{"@type":"Answer","text":"Everything that matters: inventory the AI applications, document intended use and criticality, define test metrics, secure independent test data, establish monitoring and human oversight. Every one of these building blocks can be implemented today under Annex 11, with ICH Q9(R1) informing how deep the evidence needs to go. The draft makes much of this explicit for AI models and in places demands more."}}],"isPartOf":{"@id":"https:\/\/q-finity.de\/en\/eu-gmp-annex-22\/"}},{"@type":"Person","@id":"https:\/\/q-finity.de\/en\/#founder","name":"Oliver Herrmann","jobTitle":"Founder & CEO","url":"https:\/\/q-finity.de\/en\/","worksFor":{"@id":"https:\/\/q-finity.de\/en\/#organization"},"sameAs":["https:\/\/www.linkedin.com\/in\/olherrmann\/","https:\/\/virtual.ispe.org\/b\/sp\/oliver-herrmann-4399","https:\/\/www.wikidata.org\/wiki\/Q141257562"],"knowsAbout":["GxP-Compliance","Computer System Validation","Computer Software Assurance","Data Integrity","ALCOA++","AI Governance","GAMP 5"],"image":"https:\/\/mlsqau6zetur.i.optimole.com\/cb:mN7M.c4bb\/w:auto\/h:auto\/q:mauto\/f:best\/https:\/\/q-finity.de\/wp-content\/uploads\/2026\/06\/oliver-herrmann-qfinity-ceo-scaled.jpg","description":"Founder and CEO of QFINITY, GAMP Europe Chair, qualified GAMP 5 and GAMP Data Integrity trainer, GQMA auditor and international speaker. Co-author of several ISPE GAMP guides, including the GAMP 5 Guide (2nd Edition).","memberOf":{"@type":"Organization","name":"International Society for Pharmaceutical Engineering (ISPE)","url":"https:\/\/ispe.org"},"hasCredential":[{"@type":"EducationalOccupationalCredential","credentialCategory":"degree","name":"Graduate Computer Scientist (Dipl.-Inf.)"},{"@type":"EducationalOccupationalCredential","credentialCategory":"certification","name":"Microsoft Certified Systems Engineer (MCSE)"},{"@type":"EducationalOccupationalCredential","credentialCategory":"certification","name":"SAFe (Scaled Agile Framework)"}]}]}},"_links":{"self":[{"href":"https:\/\/q-finity.de\/en\/wp-json\/wp\/v2\/pages\/16850","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/q-finity.de\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/q-finity.de\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/q-finity.de\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/q-finity.de\/en\/wp-json\/wp\/v2\/comments?post=16850"}],"version-history":[{"count":5,"href":"https:\/\/q-finity.de\/en\/wp-json\/wp\/v2\/pages\/16850\/revisions"}],"predecessor-version":[{"id":17106,"href":"https:\/\/q-finity.de\/en\/wp-json\/wp\/v2\/pages\/16850\/revisions\/17106"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/q-finity.de\/en\/wp-json\/wp\/v2\/media\/16858"}],"wp:attachment":[{"href":"https:\/\/q-finity.de\/en\/wp-json\/wp\/v2\/media?parent=16850"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}